BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 25333834)

  • 1. Select biomarkers for tumors of the gastrointestinal tract: present and future.
    Bartley AN; Hamilton SR
    Arch Pathol Lab Med; 2015 Apr; 139(4):457-68. PubMed ID: 25333834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Personalized Approaches to Gastrointestinal Cancers: Importance of Integrating Genomic Information to Guide Therapy.
    He J; Ahuja N
    Surg Clin North Am; 2015 Oct; 95(5):1081-94. PubMed ID: 26315525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changing pathology with changing drugs: tumors of the gastrointestinal tract.
    Cervera P; Fléjou JF
    Pathobiology; 2011; 78(2):76-89. PubMed ID: 21677471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarkers for personalized oncology: recent advances and future challenges.
    Kalia M
    Metabolism; 2015 Mar; 64(3 Suppl 1):S16-21. PubMed ID: 25468140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening in GI Cancers: The Role of Genetics.
    Stoffel EM
    J Clin Oncol; 2015 Jun; 33(16):1721-8. PubMed ID: 25918283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Personalized oncology: recent advances and future challenges.
    Kalia M
    Metabolism; 2013 Jan; 62 Suppl 1():S11-4. PubMed ID: 22999010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers in gastroenterology: between hope and hype comes histopathology.
    Jankowski JA; Odze RD
    Am J Gastroenterol; 2009 May; 104(5):1093-6. PubMed ID: 19417749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multigene profiling to identify alternative treatment options for glioblastoma: a pilot study.
    Tabone T; Abuhusain HJ; Nowak AK; ; Erber WN; McDonald KL
    J Clin Pathol; 2014 Jul; 67(7):550-5. PubMed ID: 24695838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perspectives of clinical proteomics in gastrointestinal cancer.
    Ebert M; Xing X; Burgermeister E; Schmid R; Röcken C
    Expert Rev Anticancer Ther; 2007 Apr; 7(4):465-9. PubMed ID: 17428167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissular and soluble miRNAs for diagnostic and therapy improvement in digestive tract cancers.
    Albulescu R; Neagu M; Albulescu L; Tanase C
    Expert Rev Mol Diagn; 2011 Jan; 11(1):101-20. PubMed ID: 21171925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular biomarkers in esophageal, gastric, and colorectal adenocarcinoma.
    Tänzer M; Liebl M; Quante M
    Pharmacol Ther; 2013 Nov; 140(2):133-47. PubMed ID: 23791941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Company profile: Sequenom, Inc.
    Cantor CR
    Pharmacogenomics; 2012 Apr; 13(5):529-31. PubMed ID: 22462745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Personalizing oncology: perspectives and prospects.
    Mendelsohn J
    J Clin Oncol; 2013 May; 31(15):1904-11. PubMed ID: 23589547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers in lung adenocarcinoma: a decade of progress.
    Sholl LM
    Arch Pathol Lab Med; 2015 Apr; 139(4):469-80. PubMed ID: 25255293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarkers and oncology: the path forward to a learning health system.
    Yu PP; Hoffman MA; Hayes DF
    Arch Pathol Lab Med; 2015 Apr; 139(4):451-6. PubMed ID: 25152310
    [No Abstract]   [Full Text] [Related]  

  • 16. Application of immunohistochemistry in gastrointestinal and liver neoplasms: new markers and evolving practice.
    Chen ZE; Lin F
    Arch Pathol Lab Med; 2015 Jan; 139(1):14-23. PubMed ID: 25549141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upper gastrointestinal cancer predisposition syndromes.
    Shah MA; Kurtz RC
    Hematol Oncol Clin North Am; 2010 Oct; 24(5):815-35. PubMed ID: 20816576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New approaches to early detection, estimation of prognosis and therapy for malignant tumours of the gastrointestinal tract].
    Röcken C; Neumann U; Ebert MP
    Z Gastroenterol; 2008 Feb; 46(2):216-22. PubMed ID: 18253902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Individualized targeted therapy for glioblastoma: fact or fiction?
    Weller M; Stupp R; Hegi M; Wick W
    Cancer J; 2012; 18(1):40-4. PubMed ID: 22290256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarkers for personalized medicine in GI cancers.
    Zhang SY; Zhang SQ; Nagaraju GP; El-Rayes BF
    Mol Aspects Med; 2015 Nov; 45():14-27. PubMed ID: 26054566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.